Glucagon-like peptide-1 (GLP-1) receptor agonists have rapidly expanded beyond their initial role in diabetes management, demonstrating therapeutic potential across a range of non-diabetic conditions. Due to their potential to improve mortality and morbidity o... ...

请注册登录后继续浏览